Breast cancer is the second most common cancer in American women, and the second leading cause of cancer deaths in women, according to the American Cancer Society. It claimed the lives of more than 41,000 women in the United States in 2019 and changed the lives of 3.5 million breast cancer survivors.
At the University of Notre Dame, a research team led by Thomas O’Sullivan, assistant professor of electrical engineering and an expert in biomedical optical sensing and imaging, hopes to revolutionize breast cancer treatment by developing the first “smart” breast marker clip.
“As researchers, we were seeking a way to provide the most relevant and timely information possible to indicate that a tumor or metastasis was either responding to or becoming resistant to treatment,” says O’Sullivan. “Since marker clips were already routinely introduced in breast tumors, we began to envision ways to create ‘smart’ versions of these markers that could provide that information in near real-time so they could be used to optimize treatment at the earliest possible opportunity.”
About the size of a sesame seed, breast marker clips are commonly placed in the body during a biopsy, where breast tissue was removed. The biologically safe clip “marks” the biopsy area and can be seen on post-biopsy mammograms to more quickly identify the affected tissue.
O’Sullivan and his team are developing a wireless, low-power, light-based sensor the size of standard breast marker clips. However, instead of simply marking the place of the abnormal tissue, the sensor continuously measures the composition of the surrounding breast tissue — without potentially toxic contrast agents or ionizing radiation — and relays it to a handheld device, similar to a glucose monitor.
Information obtained from the smart clip would allow physicians to quickly access and respond to the data regarding the regression or progression of the disease and personalize treatment for each patient based on the data received from the smart clip.
The clip could also be used to monitor benign breast lesions that are at high risk of becoming cancerous. This would decrease the number of mammograms and scans employing radioactive tracers that a woman would typically need to undergo for her physician to obtain comparable information about a lesion.
In addition to fabricating a functional smart breast clip system, the team will demonstrate the safety of the clip — to ensure that the low-power device does not affect tumor growth — and, using mouse models, validate that the smart clip can track how a tumor responds during chemotherapy.
The team includes Alicia Wei, a student in the Bioengineering Graduate Program; Siyuan Zhang, the Nancy Dee Associate Professor of Cancer Research at the Mike and Josie Harper Cancer Research Institute and associate professor of biological sciences at Notre Dame; and Joshua R. Smith, the Milton and Delia Zeutschel Professor in Entrepreneurial Excellence and director of the Sensor Systems Laboratory at the University of Washington.
The three-year project is funded in part by the Department of Defense’s Breast Cancer Research Program.The views expressed in this article are those of the a uthor and may not reflect the official policy or position of the Department of the Army, Department of Defense or the U.S. Government.